The routine urine culture is the most common test performed in hospital microbiology laboratories. This is due, in part, to the fact that urinary tract infections (UTIs) are the most prevalent infections among otherwise healthy people. Although most UTIs are not life threatening, untreated infections may result in protracted illness and serious disease, and even may result in sepsis and death.
1
To reduce the number of urine cultures performed and the associated costs, many investigators have sought to establish alternative diagnostic methods. Rapid chemical determinations of leukocyte esterase, nitrite, protein, and hemoglobin in urine specimens, as well as direct microscopy to establish the presence of leukocytes, red blood cells, and bacteria, have been proposed for urine screening before culture. According to these strategies, urine cultures would be performed only if a screening test were positive. These methods are not as sensitive or specific as direct culture methods, however, and the lack of appropriate medical treatment based on false-negative results can have serious clinical implications.
2,4~9
Requests for multiple and frequently repeated urine cultures from the same patient are common occurrences. The medical utility of repeated cultures over short periods, however, has not been documented satisfactorily, particularly when the results of initial culture are consistent with clinical findings. clinical and frequency criteria. Consensus standards for the frequency of urine cultures based on frequency of disease detection and advantageous outcome rarely have been adopted and rigorously enforced by clinical microbiology laboratories as the basis for specimen rejection.
In this study, we performed a retrospective analysis of urine culture data to determine whether published exclusion criteria 1 ' 3,4 would be clinically appropriate and cost-effective in a large teaching hospital (Brigham and Women's Hospital, Boston). Specifically, we established the proportion of urine cultures currently performed in our hospital that did not satisfy the exclusion criteria. From this information, we calculated the potential cost savings that would accrue through the use of exclusion criteria. We further studied the medical consequences, or lack of consequences, resulting from exclusion of urine cultures by review of charts from 587 consecutive cases during a 1-month period.
Materials and Methods Criteria for Appropriate and Inappropriate Urine Cultures
For the retrospective analysis of patient data, one urine culture was appropriate if any of the following criteria were met:
• Clinical symptoms suggested UTI.
• A fever of unknown origin was reported.
• The patient had symptoms of serious illness (ie, unconsciousness, symptoms of septic shock).
• The cultured sample was obtained before any planned urinary tract manipulations (long-term catheterization, cystoscopy, surgical procedure).
• The patient was at high risk for UTI, (eg, had a history of recurrent UTI or prostatitis, indwelling catheterization, pregnancy, serious underlying disease or disability, poorly controlled diabetes mellitus, immunosuppression, hematologic disorders, malignancy, or profound obesity).
If the initial culture was negative, a repeat culture was considered inappropriate unless the clinical conditions changed so that one of the above criteria was met. If the initial culture was positive and the patient was treated with an antimicrobial agent to which the isolate was susceptible, a repeat urine culture after 72 hours of treatment was considered appropriate if the clinical response to therapy was not satisfactory. Other repeat urine cultures were considered appropriate if the following conditions were met:
• The culture was performed 2 to 3 days after the end of therapy to determine whether the organism had been eliminated.
• The culture was performed 7 to 10 days after the initial culture for an untreated patient (eg, one at low risk or a catheterized patient with no symptoms).
• The results of an initial culture were not consistent with clinical findings.
• A culture yielded a mixed microflora (two or more isolates), a UTI was suspected on clinical grounds, and the patient was not receiving antibiotics.
• The patient was extremely ill and catheterized (eg, a patient in an intensive care unit).
In such cases urine cultures were considered justifiable once or twice per week. If, however, the clinician had clinical reasons to suspect an active UTI, more frequent urine cultures were considered to be justified.
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Laboratory Data Review
Twelve consecutive months of culture data (September 1992 through August 1993) obtained from the BWH clinical microbiology laboratory were used to extract information about the number of urine specimens sent to the laboratory for culture. The data elements included the patient's identification number, the laboratory accession number, date of culture, patient's location, culture results, and antibiograms for positive cultures.
Information from the hospital computer system was downloaded into a commercially available database for an IBM PC (Paradox, Borland International, Scotts Valley, Calif). A subroutine then was constructed for collating data and to identify urine cultures that did not meet the frequency criteria. Data then were summarized for comparative purposes.
Chart Review
The results for 3,500 urine samples from 2,416 patients cultured during January 1993 were reviewed by one of the authors (R. O-W). Five hundred eighty-seven patients had more than one sample cultured during this month; this group accounted for 1,683 urine cultures. The medical records for this group of patients were assessed for some reasonable clinical justification for multiple urine cultures that were not consistent with the time criteria.
Results
A summary of the laboratory data analysis is shown in Table 1 . Of 38,100 urine cultures, 5,578 (14.64%) were identified as being inappropriate or unnecessary according to the criteria outlined above. To verify these preliminary findings, we reviewed patients' records for 1 month (3,500 urine cultures) and determined whether the frequency-based criteria were consistent with clinical criteria and medical judgment ( Table 2 ). Of 786 specimens that did not appear to be consistent with these criteria (22.45% of all urine cultures), 571 (16.31%) could have been excluded on the basis of time criteria alone, and 215 (6.14%) could have been excluded on the basis of clinical criteria alone. Specimens that could have been excluded on the basis of either time or clinical criteria were counted as time criteria exclusions, because this is the most likely method for excluding repeat specimens in the laboratory. The financial impact of these unnecessary cultures was assessed by an analysis of direct costs to the laboratory, including supplies and labor. Supervision, indirect costs, and overhead items were not included. The estimated direct cost savings that could have accrued to the laboratory if these specimens had not been processed was $2,340 per month (Table 3) .
Discussion
This study was motivated by the need to determine the potential impact of changing the paradigm for urine cultures. Using consensus information on the medical indications for urine cultures, we evaluated the extent of inappropriate, or unnecessary, repeat cultures. A significant number of urine cultures were unnecessary as judged by time and/or clinical criteria. Although it would have been possible to use even more stringent criteria for exclusion of specimens, we chose to use a more conservative approach to avoid overstating the potential savings. Even with our conservative approach, the annual direct cost savings to the microbiology laboratory would be significant if these cultures were not performed.
We recognize that a change in clinical or laboratory policies such as implementation of the exclusion criteria employed in this study entails overcoming substantial barriers of ingrained practices and beliefs. Establishing or changing culture protocols and initiating rules for rejecting specimens is always difficult. Such changes would be particularly problematic for physicians to accept if only financial reasons were given. In the present study, we have shown that incorporating more stringent urine culture exclusion rules would be unlikely to result in adverse medical outcomes. Exclusion of unnecessary urine cultures from the laboratory workload would result in significant annual direct cost savings. At the present time, the exclusion criteria outlined in this study are being incorporated into a hospitalwide computerized order entry system. A measurement of the success of this effort will be determined after the criteria have been in use for a sufficient period to provide comparative information.®
